Is non-prescription oseltamivir availability under strict criteria workable? A qualitative study in New Zealand
Author(s) -
Natalie Gauld,
Fiona Kelly,
John Shaw
Publication year - 2010
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkq409
Subject(s) - medical prescription , oseltamivir , pharmacist , public health , medicine , business , qualitative research , sample (material) , recall , family medicine , pharmacy , medical emergency , nursing , psychology , covid-19 , chemistry , disease , pathology , chromatography , infectious disease (medical specialty) , cognitive psychology , social science , sociology
in 2007, New Zealand became the first country to make oseltamivir (Tamiflu) available off prescription. Strict rules for supply were developed to ensure that potential public health benefits were balanced against possible risks. We wished to explore the success of implementing this unique decision through elucidating pharmacists' attitudes to and experiences of non-prescription supply of oseltamivir.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom